Patrik Jonsson, the head of pharmaceutical behemoth Eli Lilly, said he expects orforgilpron to be available as early as next year, if approved by regulators.

Patrik Jonsson, the head of pharmaceutical behemoth Eli Lilly, said he expects orforgilpron to be available as early as next year, if approved by regulators.

Eli Lilly’s new pill could offer an easier path to weight loss for needle-averse patients